Gaxos.ai (NASDAQ:GXAI) & InnovAge (NASDAQ:INNV) Head to Head Survey

InnovAge (NASDAQ:INNV) and Gaxos.ai (NASDAQ:GXAI) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, earnings, profitability, analyst recommendations, institutional ownership and valuation.

Profitability

This table compares InnovAge and Gaxos.ai’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
InnovAge	-0.26%	-1.03%	-0.47%
Gaxos.ai	-64.81%	-38.79%	-36.99%

Valuation and Earnings

This table compares InnovAge and Gaxos.ai”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InnovAge	$989.71 million	1.26	-$2.54 million	($0.02)	-456.50
Gaxos.ai	$1.93 million	2.53	-$3.90 million	($0.50)	-0.91

InnovAge has higher revenue and earnings than Gaxos.ai. InnovAge is trading at a lower price-to-earnings ratio than Gaxos.ai, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for InnovAge and Gaxos.ai, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InnovAge	2	1	1	0	1.75
Gaxos.ai	1	0	0	0	1.00

InnovAge presently has a consensus target price of $10.50, indicating a potential upside of 15.01%. Given InnovAge’s stronger consensus rating and higher probable upside, equities research analysts plainly believe InnovAge is more favorable than Gaxos.ai.

Insider and Institutional Ownership

12.3% of InnovAge shares are held by institutional investors. Comparatively, 42.6% of Gaxos.ai shares are held by institutional investors. 1.0% of InnovAge shares are held by insiders. Comparatively, 3.2% of Gaxos.ai shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Risk and Volatility

InnovAge has a beta of 0.15, suggesting that its stock price is 85% less volatile than the S&P 500. Comparatively, Gaxos.ai has a beta of 1.08, suggesting that its stock price is 8% more volatile than the S&P 500.

Summary

InnovAge beats Gaxos.ai on 9 of the 14 factors compared between the two stocks.

About InnovAge

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.

About Gaxos.ai

Gaxos.ai Inc. engages in developing artificial intelligence applications for various sectors. Its portfolio includes applications in mental and physical wellbeing, coaching, and gaming. In addition, it offers Gaxos, a gaming platform develop, design, acquire, and manage conventional games and combine these games with unconventional game mechanisms. The company was formerly known as The NFT Gaming Company, Inc. and changed its name to Gaxos.ai Inc. in January 2024. Gaxos.ai Inc. was incorporated in 2021 and is based in Roseland, New Jersey.